Tamara Lotan

Ultrasound elastography as a tool for imaging guidance during prostatectomy: Initial experience

Gregory Hager, E. Boctor, K. Macura, 2012, Medical science monitor : international medical journal of experimental and clinical research.

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients

E. Klein, S. Freedland, R. Karnes, 2017, Oncotarget.

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial

J. Proudfoot, D. Berney, M. Parmar, 2023, Research square.

Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial

Hao Wang, P. Tran, J. Hearn, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: Exploratory analysis from 12,076 patients.

E. Klein, S. Freedland, R. Karnes, 2017, Oncotarget.

Xanthomatous Giant Cell Renal Cell Carcinoma

Lisa M Haley, P. Argani, R. Mehra, 2022, The American journal of surgical pathology.

NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

A. D'Amico, J. Eastham, M. Roach, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial

J. Proudfoot, D. Berney, M. Parmar, 2023, Research square.